Pinnacle Associates’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-619	Closed	-$2.05K	–	777
2022 Q4	$2.05K	Sell	619 -26,956	-98%	-$104K	﹤0.01%	758
2022 Q3	$136K	Sell	27,575 -2,759	-9%	-$19.5K	﹤0.01%	710
2022 Q2	$230K	Sell	30,334 -162	-0.5%	-$1.57K	0.01%	670
2022 Q1	$486K	Sell	30,496 -1,073	-3%	-$14.2K	0.01%	567
2021 Q4	$583K	Sell	31,569 -631	-2%	-$17.1K	0.01%	532
2021 Q3	$985K	Sell	32,200 -1,074	-3%	-$42.4K	0.02%	444
2021 Q2	$1.83M	Buy	33,274 +498	+2%	+$27.6K	0.03%	347
2021 Q1	$1.94M	Buy	32,776 +1,373	+4%	+$90.3K	0.04%	327
2020 Q4	$1.18M	Sell	31,403 -7,378	-19%	-$276K	0.02%	376
2020 Q3	$2.09M	Sell	38,781 -1,366	-3%	-$247K	0.05%	270
2020 Q2	$10.1M	Sell	40,147 -646	-2%	-$131K	0.25%	110
2020 Q1	$6.41M	Buy	+40,793	New	+$6.9M	0.19%	130